Cargando…

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations

Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Pottier, Cyril, Mateiu, Ligia, Baker, Matthew C, DeJesus-Hernandez, Mariely, Teixeira Vicente, Cristina, Finch, NiCole A, Tian, Shulan, van Blitterswijk, Marka, Murray, Melissa E, Ren, Yingxue, Petrucelli, Leonard, Oskarsson, Björn, Biernacka, Joanna M, Graff-Radford, Neill R, Boeve, Bradley F, Petersen, Ronald C, Josephs, Keith A, Asmann, Yan W, Dickson, Dennis W, Rademakers, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337811/
https://www.ncbi.nlm.nih.gov/pubmed/34918030
http://dx.doi.org/10.1093/brain/awab437
_version_ 1784759835738243072
author Pottier, Cyril
Mateiu, Ligia
Baker, Matthew C
DeJesus-Hernandez, Mariely
Teixeira Vicente, Cristina
Finch, NiCole A
Tian, Shulan
van Blitterswijk, Marka
Murray, Melissa E
Ren, Yingxue
Petrucelli, Leonard
Oskarsson, Björn
Biernacka, Joanna M
Graff-Radford, Neill R
Boeve, Bradley F
Petersen, Ronald C
Josephs, Keith A
Asmann, Yan W
Dickson, Dennis W
Rademakers, Rosa
author_facet Pottier, Cyril
Mateiu, Ligia
Baker, Matthew C
DeJesus-Hernandez, Mariely
Teixeira Vicente, Cristina
Finch, NiCole A
Tian, Shulan
van Blitterswijk, Marka
Murray, Melissa E
Ren, Yingxue
Petrucelli, Leonard
Oskarsson, Björn
Biernacka, Joanna M
Graff-Radford, Neill R
Boeve, Bradley F
Petersen, Ronald C
Josephs, Keith A
Asmann, Yan W
Dickson, Dennis W
Rademakers, Rosa
author_sort Pottier, Cyril
collection PubMed
description Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 24 FTLD-TDP patients with GRN mutations and 24 control participants. Using principal component analysis, hierarchical clustering, differential expression and coexpression network analyses, we showed that GRN mutation carriers and FTLD-TDP-A patients without a known mutation shared a common transcriptional signature that is independent of GRN loss-of-function. After combining both groups, differential expression as compared to the control group and coexpression analyses revealed alteration of processes related to immune response, synaptic transmission, RNA metabolism, angiogenesis and vesicle-mediated transport. Deconvolution of the data highlighted strong cellular alterations that were similar in FTLD-TDP-A and GRN mutation carriers with NSF as a potentially important player in both groups. We propose several potentially druggable pathways such as the GABAergic, GDNF and sphingolipid pathways. Our findings underline new disease mechanisms and strongly suggest that affected pathways in GRN mutation carriers extend beyond GRN and contribute to genetically unexplained forms of FTLD-TDP-A.
format Online
Article
Text
id pubmed-9337811
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93378112022-08-01 Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations Pottier, Cyril Mateiu, Ligia Baker, Matthew C DeJesus-Hernandez, Mariely Teixeira Vicente, Cristina Finch, NiCole A Tian, Shulan van Blitterswijk, Marka Murray, Melissa E Ren, Yingxue Petrucelli, Leonard Oskarsson, Björn Biernacka, Joanna M Graff-Radford, Neill R Boeve, Bradley F Petersen, Ronald C Josephs, Keith A Asmann, Yan W Dickson, Dennis W Rademakers, Rosa Brain Original Article Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) is a complex heterogeneous neurodegenerative disorder for which mechanisms are poorly understood. To explore transcriptional changes underlying FTLD-TDP, we performed RNA-sequencing on 66 genetically unexplained FTLD-TDP patients, 24 FTLD-TDP patients with GRN mutations and 24 control participants. Using principal component analysis, hierarchical clustering, differential expression and coexpression network analyses, we showed that GRN mutation carriers and FTLD-TDP-A patients without a known mutation shared a common transcriptional signature that is independent of GRN loss-of-function. After combining both groups, differential expression as compared to the control group and coexpression analyses revealed alteration of processes related to immune response, synaptic transmission, RNA metabolism, angiogenesis and vesicle-mediated transport. Deconvolution of the data highlighted strong cellular alterations that were similar in FTLD-TDP-A and GRN mutation carriers with NSF as a potentially important player in both groups. We propose several potentially druggable pathways such as the GABAergic, GDNF and sphingolipid pathways. Our findings underline new disease mechanisms and strongly suggest that affected pathways in GRN mutation carriers extend beyond GRN and contribute to genetically unexplained forms of FTLD-TDP-A. Oxford University Press 2021-12-16 /pmc/articles/PMC9337811/ /pubmed/34918030 http://dx.doi.org/10.1093/brain/awab437 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Pottier, Cyril
Mateiu, Ligia
Baker, Matthew C
DeJesus-Hernandez, Mariely
Teixeira Vicente, Cristina
Finch, NiCole A
Tian, Shulan
van Blitterswijk, Marka
Murray, Melissa E
Ren, Yingxue
Petrucelli, Leonard
Oskarsson, Björn
Biernacka, Joanna M
Graff-Radford, Neill R
Boeve, Bradley F
Petersen, Ronald C
Josephs, Keith A
Asmann, Yan W
Dickson, Dennis W
Rademakers, Rosa
Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
title Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
title_full Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
title_fullStr Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
title_full_unstemmed Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
title_short Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
title_sort shared brain transcriptomic signature in tdp-43 type a ftld patients with or without grn mutations
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9337811/
https://www.ncbi.nlm.nih.gov/pubmed/34918030
http://dx.doi.org/10.1093/brain/awab437
work_keys_str_mv AT pottiercyril sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT mateiuligia sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT bakermatthewc sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT dejesushernandezmariely sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT teixeiravicentecristina sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT finchnicolea sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT tianshulan sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT vanblitterswijkmarka sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT murraymelissae sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT renyingxue sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT petrucellileonard sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT oskarssonbjorn sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT biernackajoannam sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT graffradfordneillr sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT boevebradleyf sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT petersenronaldc sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT josephskeitha sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT asmannyanw sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT dicksondennisw sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations
AT rademakersrosa sharedbraintranscriptomicsignatureintdp43typeaftldpatientswithorwithoutgrnmutations